Published in Biochem Biophys Res Commun on September 08, 1998
Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol (2008) 4.75
Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci U S A (2003) 2.42
Molecular pathways mediating mechanical signaling in bone. Gene (2005) 2.17
Nitric oxide and bone. Immunology (2001) 1.60
Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol (2001) 1.29
Calcium response in osteocytic networks under steady and oscillatory fluid flow. Bone (2012) 1.11
Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction. J Biol Chem (2009) 1.10
Protein kinase G and focal adhesion kinase converge on Src/Akt/β-catenin signaling module in osteoblast mechanotransduction. J Biol Chem (2012) 0.94
Cardiovascular disease and osteoporosis: balancing risk management. Vasc Health Risk Manag (2007) 0.89
Additive effects of estrogen and mechanical stress on nitric oxide and prostaglandin E2 production by bone cells from osteoporotic donors. Osteoporos Int (2004) 0.87
Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification. Dev Biol (2008) 0.86
The role of nitric oxide in the mechanical repression of RANKL in bone stromal cells. Bone (2008) 0.85
Nitric oxide signaling in mechanical adaptation of bone. Osteoporos Int (2013) 0.82
Different responsiveness to mechanical stress of bone cells from osteoporotic versus osteoarthritic donors. Osteoporos Int (2006) 0.82
Mechanotransduction in human bone: in vitro cellular physiology that underpins bone changes with exercise. Sports Med (2008) 0.82
CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts. PLoS One (2015) 0.81
Hyperosmotic Stimulus Down-regulates 1alpha, 25-dihydroxyvitamin D(3)-induced Osteoclastogenesis by Suppressing the RANKL Expression in a Co-culture System. Korean J Physiol Pharmacol (2010) 0.79
The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]. Trials (2006) 0.78
Blood pressure, artery size, and artery compliance parallel bone size and strength in mice with differing ece1 expression. J Biomech Eng (2013) 0.78
Blood and interstitial flow in the hierarchical pore space architecture of bone tissue. J Biomech (2014) 0.77
Regulation of skeletal remodeling by biomechanical input. Osteoporos Int (2003) 0.76
Synergic induction of human periodontal ligament fibroblast cell death by nitric oxide and N-methyl-D-aspartic acid receptor antagonist. J Periodontal Implant Sci (2011) 0.76
Mechanical loading reduces inflammation-induced human osteocyte-to-osteoclast communication. Calcif Tissue Int (2015) 0.76
Expression of endothelial nitric oxide synthase protein is not necessary for mechanical strain-induced nitric oxide production by cultured osteoblasts. Osteoporos Int (2012) 0.75
Fluoride inhibits the response of bone cells to mechanical loading. Odontology (2011) 0.75
Mineralisation defects with pamidronate therapy for Paget's disease. Lancet (1993) 2.76
Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med (1998) 2.64
Randomised controlled trial of a short course of traditional acupuncture compared with usual care for persistent non-specific low back pain. BMJ (2006) 2.63
Management of Paget's disease of bone. Rheumatology (Oxford) (2004) 2.60
Sensitivity of osteocytes to biomechanical stress in vitro. FASEB J (1995) 2.53
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Guidelines on the management of Paget's disease of bone. Bone (2002) 2.34
Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics (1994) 2.33
Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet (1996) 2.23
Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain. Health Technol Assess (2005) 2.21
Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia. Lancet (1985) 2.15
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet (2000) 2.13
A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest (2001) 1.98
The production of nitric oxide and prostaglandin E(2) by primary bone cells is shear stress dependent. J Biomech (2001) 1.84
How safe is acupuncture? Developing the evidence on risk. J Altern Complement Med (1999) 1.82
Function of osteocytes in bone. J Cell Biochem (1994) 1.74
Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis Rheum (1999) 1.70
Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res (2000) 1.70
Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev (1986) 1.68
Why does intermittent hydrostatic pressure enhance the mineralization process in fetal cartilage? J Biomech (1999) 1.66
A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis. BMJ (2006) 1.65
Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol (2000) 1.62
Pulsating fluid flow increases prostaglandin production by cultured chicken osteocytes--a cytoskeleton-dependent process. Biochem Biophys Res Commun (1996) 1.61
Nitric oxide and bone. Immunology (2001) 1.60
Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res (1991) 1.57
Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. J Bone Miner Res (1991) 1.57
In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med (1982) 1.56
Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53
Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibroblasts--correlation with prostaglandin upregulation. Biochem Biophys Res Commun (1995) 1.51
Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin. Br Med J (Clin Res Ed) (1986) 1.47
Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone (2003) 1.44
A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation. Oncogene (2000) 1.43
The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Cancer Res (1998) 1.39
Signal transduction pathways involved in fluid flow-induced PGE2 production by cultured osteocytes. Am J Physiol (1999) 1.38
Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res (1995) 1.37
Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium. Clin Sci (Lond) (1984) 1.36
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone (2001) 1.35
Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis (1995) 1.34
Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology (2001) 1.32
Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res (1998) 1.25
Patient perspectives on outcomes after treatment with acupuncture. J Altern Complement Med (2001) 1.23
Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells. J Bone Miner Res (1997) 1.23
Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem (2001) 1.22
Mechanotransduction of bone cells in vitro: mechanobiology of bone tissue. Med Biol Eng Comput (2004) 1.19
Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol (2000) 1.18
Mechanical stimulation of osteopontin mRNA expression and synthesis in bone cell cultures. J Cell Physiol (1997) 1.17
Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. Bone (1996) 1.14
Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am J Hum Genet (2001) 1.14
Growth of osteoclast precursor-like cells from whole mouse bone marrow: inhibitory effect of CSF-1. Bone Miner (1987) 1.14
Collagen Ialpha1 Sp1 polymorphism, bone mass, and bone turnover in healthy French premenopausal women: the OFELY study. J Bone Miner Res (1998) 1.13
Abnormal growth factor and cytokine expression in Dupuytren's contracture. J Clin Pathol (1993) 1.13
Mechanical stimulation by intermittent hydrostatic compression promotes bone-specific gene expression in vitro. J Biomech (1995) 1.11
Bacteroides gingivalis stimulates bone resorption via interleukin-1 production by mononuclear cells. The relative role for B. gingivalis endotoxin. J Clin Periodontol (1990) 1.11
Is BMU-coupling a strain-regulated phenomenon? A finite element analysis. J Bone Miner Res (2000) 1.10
Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. J Immunol (1997) 1.09
Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone (1997) 1.08
Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology (1996) 1.08
Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet (2005) 1.08
Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia (1998) 1.08
Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum (2001) 1.07
A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res (2000) 1.07
Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer (1991) 1.06
Demonstration of tartrate-resistant acid phosphatase in un-decalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification. J Histochem Cytochem (1986) 1.06
Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy. Br Med J (Clin Res Ed) (1984) 1.05
Longer-term clinical and economic benefits of offering acupuncture to patients with chronic low back pain assessed as suitable for primary care management. Complement Ther Med (1999) 1.04
Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats. J Clin Invest (1994) 1.04
An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women. J Bone Miner Res (1998) 1.04
Familial Paget's disease of bone: patterns of inheritance and frequency of linkage to chromosome 18q. Bone (2000) 1.04
Low-intensity pulsed ultrasound affects human articular chondrocytes in vitro. Med Biol Eng Comput (2008) 1.03
Attitudes of GPs towards the provision of acupuncture on the NHS. Complement Ther Med (2003) 1.03
Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity. J Bone Miner Res (1998) 1.02
Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy. Bone Miner (1991) 1.02
Too much heparin: possible source of error in blood gas analysis. Br Med J (Clin Res Ed) (1983) 1.02
Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J Cell Biol (1991) 1.02
Origin of a negative calcium response element in an ALU-repeat: implications for regulation of gene expression by extracellular calcium. Bone (1995) 1.01
Non-cardiac chest pain: a retrospective cohort study of patients who attended a Rapid Access Chest Pain Clinic. Fam Pract (2007) 1.01
Clinical experience with pamidronate in the treatment of Paget's disease of bone. Ann Rheum Dis (1991) 1.01
Cross-calibration of dual-energy X-ray densitometers for a large, multi-center genetic study of osteoporosis. Osteoporos Int (2005) 1.00
Spatial organization of microfilaments and vitronectin receptor, alpha v beta 3, in osteoclasts. A study using confocal laser scanning microscopy. J Cell Sci (1993) 1.00
Intrapulmonary epinephrine during prolonged cardiopulmonary resuscitation: improved regional blood flow and resuscitation in dogs. Ann Emerg Med (1984) 1.00
Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J Bone Miner Res (1997) 1.00
Clinical determinants of quality of life in Paget's disease of bone. Calcif Tissue Int (2007) 1.00
Mineralization processes in demineralized bone matrix grafts in human maxillary sinus floor elevations. J Biomed Mater Res (1999) 1.00
Use of recombinant human osteogenic protein-1 for the repair of subchondral defects in articular cartilage in goats. J Biomed Mater Res (2000) 0.99
Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. J Clin Periodontol (2000) 0.99
Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts. J Cell Sci (1993) 0.99
Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol (1997) 0.99
Donor age and mechanosensitivity of human bone cells. Osteoporos Int (2002) 0.99